We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Review · October 05, 2020

Disease Mechanism, Biomarkers, and Therapeutics for Spinal and Bulbar Muscular Atrophy

Journal of Neurology, Neurosurgery, and Psychiatry

 

Additional Info

Journal of Neurology, Neurosurgery, and Psychiatry
Disease Mechanism, Biomarker and Therapeutics for Spinal and Bulbar Muscular Atrophy (SBMA)
J. Neurol. Neurosurg. Psychiatr. 2020 Oct 01;91(10)1085-1091, A Hashizume, KH Fischbeck, M Pennuto, P Fratta, M Katsuno

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading